Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q2 2016 · 10-Q
Revenue$1.13M$1.13M−30.2% vs Q2 2015 Net Income-$6.41M-$6.41MN/M vs Q2 2015 EPS Diluted-$0.43-$0.43N/M vs Q2 2015 Gross Profit$541,000+70.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,677,000N/M Free Cash Flowderived-$5,713,000N/M Margins · derivedGross margin48.0%+28.3 pt vs Q2 2015
Operating margin-552.8%
Net margin-568.8%
ended Jun 30, 2016 · filed Aug 5, 2016 · 36 d after period end